Extended Data Fig. 5: Median change and percentage change from baseline over time in pharmacodynamic markers.
From: Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial
a, b, Serum thymus and activation-regulated chemokine (TARC). c, d, Serum total immunoglobulin E (IgE). e, f, Plasma eotaxin-3. g, h, Blood eosinophil count. i, j, Blood eosinophil percentage. Comparisons between groups were analyzed using two-sided Wilcoxon rank-sum test, and P values were nominal without adjustments for multiple comparisons. Error bars denote interquartile ranges.
